Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Advanced Pancreatic Carcinoma: early-phase trial registry

2 of 4 indexed Advanced Pancreatic Carcinoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Advanced Pancreatic Carcinoma: 4 US clinical trials tracked, 2 recruiting.

Advanced Pancreatic Carcinoma is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Sameek Roychowdhury, running 1 of these trials.

Enrollment posture brief

Registry condition advanced-pancreatic-carcinoma

OPEN 2 | RECR 50% | LATE 0 | EARLY 4 | RANK #4115 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Advanced Pancreatic Carc (th…50%
Open-enrollment share among volume-matched conditions near Advanced Pancreatic Carcinoma

Advanced Pancreatic Carcinoma lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Advanced Pancreatic Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Advanced Pancreatic Carcinoma is recruiting above its size-band peers.

    2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 24

Phase Distribution

PhaseTrial count
Phase 2 4

Top Sponsors

Named interventions

Most-linked intervention names on Advanced Pancreatic Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Bone Scan Procedure
2 trials
Photodynamic Therapy Drug
1 trials
Fluorescence Imaging Procedure
1 trials
Optical Coherence Tomography Procedure
1 trials
Pemigatinib Drug
1 trials
Gemcitabine Hydrochloride Drug
1 trials
Devimistat Drug
1 trials
Echocardiography Procedure
1 trials

US sites by state

Facility locations filed on Advanced Pancreatic Carcinoma trials. A trial with sites in several states counts in each.

Oregon 1 trials
Minnesota 1 trials
Illinois 1 trials
Florida 1 trials
Delaware 1 trials
Connecticut 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Advanced Pancreatic Carcinoma page

4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Advanced Pancreatic Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Sameek Roychowdhury sponsors the most Advanced Pancreatic Carcinoma trials on record, review their full trial history before evaluating a specific study. See Sameek Roychowdhury's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Advanced Pancreatic Carcinoma condition card totals 4 registered trials; most-linked intervention Bone Scan; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.